Oxford Biomedica (OXB), a viral vector contract development and manufacturing organization (CDMO), has implemented Sapio Sciences’ Electronic Laboratory Notebook (ELN) as part of its digital transformation. The integration of Sapio’s ELN is set to increase efficiency of completing tasks, and bolster the insight gained from the state-of-the-art technologies developed at OXB.

“Sapio’s configurable no-code/low-code ELN platform will help to facilitate our digital transformation at OXB, supporting us to deliver high-quality viral vector CDMO services to our clients,” said Matthew Treagus, chief information officer, Oxford Biomedica.

Kevin Cramer, CEO and founder of Sapio Sciences, said, “We are thrilled to partner with Oxford Biomedica, a front-runner in the realm of gene and cell therapy. Sapio’s Electronic Laboratory Notebook (ELN) software is built to revolutionize lab work. We are excited to see how Sapio’s ELN can help OXB to drive efficiency and deliver quality services to their clients.”